Shopping Cart
Remove All
Your shopping cart is currently empty
JNJ-89862175 is an antibody-drug conjugate (ADC) that targets ENPP3. JNJ-89862175 specifically recognizes ENPP3 on the surface of tumor cells; after endocytosis and formation of endosomes, the released payload inhibits microtubule polymerization to block mitosis, ultimately inducing tumor cell apoptosis. JNJ-89862175 is intended for use in studies of ENPP3-positive advanced solid tumors.

| Description | JNJ-89862175 is an antibody-drug conjugate (ADC) that targets ENPP3. JNJ-89862175 specifically recognizes ENPP3 on the surface of tumor cells; after endocytosis and formation of endosomes, the released payload inhibits microtubule polymerization to block mitosis, ultimately inducing tumor cell apoptosis. JNJ-89862175 is intended for use in studies of ENPP3-positive advanced solid tumors. |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.